Nikko Asset Management Americas, Inc. - CELLULAR BIOMEDICINE GROUP I ownership

CELLULAR BIOMEDICINE GROUP I's ticker is CBMG and the CUSIP is 15117P102. A total of 46 filers reported holding CELLULAR BIOMEDICINE GROUP I in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Nikko Asset Management Americas, Inc. ownership history of CELLULAR BIOMEDICINE GROUP I
ValueSharesWeighting
Q1 2020$15,082,000
+74.3%
953,346
+78.9%
0.14%
+3.7%
Q4 2019$8,653,000
+4.4%
532,825
-4.5%
0.14%
-7.5%
Q3 2019$8,288,000
-5.8%
557,752
+4.8%
0.15%
-15.0%
Q2 2019$8,799,000
+30.9%
532,318
+37.0%
0.17%
-2.3%
Q1 2019$6,721,000388,5200.18%
Other shareholders
CELLULAR BIOMEDICINE GROUP I shareholders Q2 2020
NameSharesValueWeighting ↓
PLATINUM INVESTMENT MANAGEMENT LTD 672,885$11,123,0000.26%
AWM Investment Company, Inc. 80,165$1,325,0000.25%
Nikko Asset Management Americas, Inc. 532,318$8,799,0000.17%
ARK Investment Management 314,378$5,197,0000.13%
Sumitomo Mitsui Trust Holdings, Inc. 528,418$8,735,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 32,100$531,0000.01%
Mizuho Securities Co. Ltd. 300$5,0000.01%
GEODE CAPITAL MANAGEMENT, LLC 148,815$2,459,0000.00%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 18,629$308,0000.00%
STATE OF WISCONSIN INVESTMENT BOARD 16,100$237,0000.00%
View complete list of CELLULAR BIOMEDICINE GROUP I shareholders